Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents

Thienopyridines are a class of drug targeting the platelet adenosine diphosphate (ADP) 2 receptor. They significantly reduce platelet activity and are therefore clinically beneficial in settings where platelet activation is a key pathophysiological feature, particularly myocardial infarction. Ticlop...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, L., Biondi Zoccai, G. G. L., Valgimigli, M., Latini, R. A., Pizzocri, S., Lanotte, S., Laudisa, M. L., Brambilla, N., Ward, M. R., Figtree, G. A., Bedogni, F., Bhindi, R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997499/
https://www.ncbi.nlm.nih.gov/pubmed/21151515
http://dx.doi.org/10.1155/2010/595934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997499/
https://www.ncbi.nlm.nih.gov/pubmed/21151515
http://dx.doi.org/10.1155/2010/595934

Ejemplares similares